首页 > 最新文献

Turkish journal of urology最新文献

英文 中文
Artificial Urinary Sphincter in a High-Risk Urethra: Transcorporal Gullwing Modification Description of the Technique. 人工尿道括约肌在高危尿道:经下体鸥翼修饰技术描述。
IF 1.3 Q4 UROLOGY & NEPHROLOGY Pub Date : 2022-11-01 DOI: 10.5152/tud.2022.22134
David Hernández-Hernández, María Yanira Ortega-González, Bárbara Padilla-Fernández, David Manuel Castro-Díaz

Background: In this report, we describe a modification of transcorporal artificial urinary sphincter place ment known as Gullwing modification.

Description of technique: Using a penoscrotal approach, bilateral corpora cavernosa flaps are harvested and sutured in the midline covering the lateral and ventral surfaces of the urethra. Transcorporal cuff placement provides dorsal reinforcement, thus having extra tissue buttressing all the circumference in cases of a fragile urethra due to previous urethral cuff erosion, urethroplasty, or pelvic radiotherapy.

Patient and methods: After previous urethral cuff erosion, radiotherapy, and urethral reconstruction, our patient complained of severe stress urinary incontinence. Due to the high risk of urethral complications, we proceed to a transcorporal artificial sphincter placement with urethral reinforcement through a bilateral cavernosal flap.

Results: The surgery was successfully completed, and after 6 weeks, sphincter was activated with satisfac tory results. Two years after surgery, his continence status is stable without complications.

Conclusion: Urethral complications associated with artificial urinary sphincter surgery remain a challenge for the reconstructive surgeon. Reinforcement of the ventral aspect of the urethra through corpora cavernosal flaps may reduce the likelihood of urethral erosion in high-risk cases.

背景:在本报告中,我们描述了一种经体外人工尿道括约肌置换术的改良,称为Gullwing改良术。技术描述:采用阴囊入路,取双侧海绵体皮瓣,缝合于覆盖尿道外侧和腹侧表面的中线。经尿道袖带放置提供了背部加固,因此,在由于先前尿道袖带糜烂、尿道成形术或盆腔放疗而导致尿道脆弱的情况下,有额外的组织支撑整个尿道周长。患者和方法:我们的患者在既往尿道套糜烂,放疗和尿道重建后,主诉严重的应激性尿失禁。由于尿道并发症的高风险,我们进行经膀胱人工括约肌置入,并通过双侧海绵体皮瓣加强尿道。结果:手术顺利完成,6周后,括约肌激活,效果满意。术后2年,患者尿失禁状况稳定,无并发症。结论:人工尿道括约肌手术相关的尿道并发症仍然是尿道重建外科医生面临的一个挑战。通过海绵体皮瓣加强尿道腹侧可以减少高危病例尿道糜烂的可能性。
{"title":"Artificial Urinary Sphincter in a High-Risk Urethra: Transcorporal Gullwing Modification Description of the Technique.","authors":"David Hernández-Hernández,&nbsp;María Yanira Ortega-González,&nbsp;Bárbara Padilla-Fernández,&nbsp;David Manuel Castro-Díaz","doi":"10.5152/tud.2022.22134","DOIUrl":"https://doi.org/10.5152/tud.2022.22134","url":null,"abstract":"<p><strong>Background: </strong>In this report, we describe a modification of transcorporal artificial urinary sphincter place ment known as Gullwing modification.</p><p><strong>Description of technique: </strong>Using a penoscrotal approach, bilateral corpora cavernosa flaps are harvested and sutured in the midline covering the lateral and ventral surfaces of the urethra. Transcorporal cuff placement provides dorsal reinforcement, thus having extra tissue buttressing all the circumference in cases of a fragile urethra due to previous urethral cuff erosion, urethroplasty, or pelvic radiotherapy.</p><p><strong>Patient and methods: </strong>After previous urethral cuff erosion, radiotherapy, and urethral reconstruction, our patient complained of severe stress urinary incontinence. Due to the high risk of urethral complications, we proceed to a transcorporal artificial sphincter placement with urethral reinforcement through a bilateral cavernosal flap.</p><p><strong>Results: </strong>The surgery was successfully completed, and after 6 weeks, sphincter was activated with satisfac tory results. Two years after surgery, his continence status is stable without complications.</p><p><strong>Conclusion: </strong>Urethral complications associated with artificial urinary sphincter surgery remain a challenge for the reconstructive surgeon. Reinforcement of the ventral aspect of the urethra through corpora cavernosal flaps may reduce the likelihood of urethral erosion in high-risk cases.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"460-464"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10818557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AHNAK2 Urinary Protein Expression as Potential Biomarker for Bladder Cancer Detection: A Pilot Study. AHNAK2尿蛋白表达作为膀胱癌检测的潜在生物标志物:一项初步研究
IF 1.3 Q4 UROLOGY & NEPHROLOGY Pub Date : 2022-11-01 DOI: 10.5152/tud.2022.22132
Selim Komina, Gordana Petrusevska, Rubens Jovanovic, Slavica Kostadinova Kunovska, Sotir Stavridis, Saso Dohcev, Skender Saidi, Sonja Topuzovska
Objective: This study aimed to measure the AHNAK2 urinary levels in bladder cancer patients. Material and methods: This prospective case–control study enrolled 67 participants between January and March 2019 and were categorized into bladder cancer group (n = 37), with histologically proven bladder cancer, and control group (n = 30), with histologically verified benign lesions or with no bladder cancer indication during follow-up. Urine samples of 15 mL were collected in the mid-morning before cystoscopy/surgery and an enzyme-linked immunosorbent assay was performed as per the manufacturer’s protocol. Bladder malignancies were classified according to the World Health Organization Tumor Classification. Group’s associations were evaluated with the Student t-test, Spearman’s rank correlation, and Mann–Whitney U test, while receiver operating curve was plotted for assessing the test’s performance. Results: Mean age of the bladder cancer group was 66.41 years (standard deviation = 10.04, range = 43-82 years) and the control group was 59.67 years (standard deviation = 10.44, range = 38-77 years). All bladder cancers were of the urothelial histotype, with the following pT distribution: pTa/papillary urothelial neoplasm of low malignant potential (n = 19; 28.4%), Primary tumor (pT) in situ (n = 4; 6%), pT1 (n = 7; 10.4%), and pT≥2 (n = 7; 10.48%). Mean AHNAK2 levels were higher in bladder cancer patients 49.08 pg/mL (standard deviation = 114.91) compared to controls 5.28 pg/mL (standard deviation = 6.65), P < .05). Significant differences were noted between non-invasive bladder cancer (n = 23; mean = 7.14 pg/mL; standard deviation = 7.26) and invasive bladder cancer (n = 14; mean = 117.99 pg/mL; standard deviation = 168.08) and between non-muscle invasive bladder cancer (mean = 23.19 pg/mL; standard deviation = 66.93) and muscle-invasive bladder cancer (mean = 160.05 pg/mL; standard deviation = 199.65) (P < .001). The result of the assays was given as follows: sensitivity: 64.19%, specificity: 66.67%, positive predictive value: 22.07%, negative predictive value: 92.37%, area under curve: 0.695, and 95% CI: 0.57-0.82. Conclusion: AHNAK2 protein could be used as bladder cancer surveillance biomarker. The inclusion of AHNAK2 levels in stratification nomograms might reduce the number of unnecessary cystoscopies.
目的:检测膀胱癌患者尿中AHNAK2水平。材料和方法:本前瞻性病例对照研究于2019年1月至3月招募了67名参与者,分为组织学证实的膀胱癌组(n=37)和对照组(n=30),随访期间组织学证实的良性病变或无膀胱癌指征。在膀胱镜检查/手术前上午收集15 mL尿液样本,并按照制造商的方案进行酶联免疫吸附试验。膀胱恶性肿瘤按照世界卫生组织肿瘤分类进行分类。采用学生t检验、Spearman秩相关检验和Mann-Whitney U检验评价组间关联,绘制受试者工作曲线评价检验效果。结果:膀胱癌组患者平均年龄为66.41岁(标准差=10.04,范围=43 ~ 82岁),对照组患者平均年龄为59.67岁(标准差=10.44,范围=38 ~ 77岁)。所有膀胱癌均为尿路上皮组织型,pT分布如下:pTa/乳头状尿路上皮肿瘤,低恶性潜能(n=19;28.4%),原发肿瘤(pT)原位(n=4;6%), pT1 (n=7;10.4%),且pT≥2 (n=7;10.48%)。膀胱癌患者的AHNAK2平均水平为49.08 pg/mL(标准差=114.91),高于对照组的5.28 pg/mL(标准差=6.65),P < 0.05。非侵袭性膀胱癌(n=23;意味着= 7.14 pg / mL;标准偏差=7.26)和浸润性膀胱癌(n=14;意味着= 117.99 pg / mL;标准偏差=168.08)和非肌性浸润性膀胱癌(平均=23.19 pg/mL;标准偏差=66.93)和肌肉浸润性膀胱癌(平均=160.05 pg/mL;标准差=199.65)(P < 0.001)。结果:敏感性为64.19%,特异性为66.67%,阳性预测值为22.07%,阴性预测值为92.37%,曲线下面积为0.695,95% CI为0.57 ~ 0.82。结论:AHNAK2蛋白可作为膀胱癌监测标志物。在分层图中包含AHNAK2水平可能会减少不必要的膀胱镜检查次数。
{"title":"AHNAK2 Urinary Protein Expression as Potential Biomarker for Bladder Cancer Detection: A Pilot Study.","authors":"Selim Komina,&nbsp;Gordana Petrusevska,&nbsp;Rubens Jovanovic,&nbsp;Slavica Kostadinova Kunovska,&nbsp;Sotir Stavridis,&nbsp;Saso Dohcev,&nbsp;Skender Saidi,&nbsp;Sonja Topuzovska","doi":"10.5152/tud.2022.22132","DOIUrl":"https://doi.org/10.5152/tud.2022.22132","url":null,"abstract":"Objective: This study aimed to measure the AHNAK2 urinary levels in bladder cancer patients. Material and methods: This prospective case–control study enrolled 67 participants between January and March 2019 and were categorized into bladder cancer group (n = 37), with histologically proven bladder cancer, and control group (n = 30), with histologically verified benign lesions or with no bladder cancer indication during follow-up. Urine samples of 15 mL were collected in the mid-morning before cystoscopy/surgery and an enzyme-linked immunosorbent assay was performed as per the manufacturer’s protocol. Bladder malignancies were classified according to the World Health Organization Tumor Classification. Group’s associations were evaluated with the Student t-test, Spearman’s rank correlation, and Mann–Whitney U test, while receiver operating curve was plotted for assessing the test’s performance. Results: Mean age of the bladder cancer group was 66.41 years (standard deviation = 10.04, range = 43-82 years) and the control group was 59.67 years (standard deviation = 10.44, range = 38-77 years). All bladder cancers were of the urothelial histotype, with the following pT distribution: pTa/papillary urothelial neoplasm of low malignant potential (n = 19; 28.4%), Primary tumor (pT) in situ (n = 4; 6%), pT1 (n = 7; 10.4%), and pT≥2 (n = 7; 10.48%). Mean AHNAK2 levels were higher in bladder cancer patients 49.08 pg/mL (standard deviation = 114.91) compared to controls 5.28 pg/mL (standard deviation = 6.65), P < .05). Significant differences were noted between non-invasive bladder cancer (n = 23; mean = 7.14 pg/mL; standard deviation = 7.26) and invasive bladder cancer (n = 14; mean = 117.99 pg/mL; standard deviation = 168.08) and between non-muscle invasive bladder cancer (mean = 23.19 pg/mL; standard deviation = 66.93) and muscle-invasive bladder cancer (mean = 160.05 pg/mL; standard deviation = 199.65) (P < .001). The result of the assays was given as follows: sensitivity: 64.19%, specificity: 66.67%, positive predictive value: 22.07%, negative predictive value: 92.37%, area under curve: 0.695, and 95% CI: 0.57-0.82. Conclusion: AHNAK2 protein could be used as bladder cancer surveillance biomarker. The inclusion of AHNAK2 levels in stratification nomograms might reduce the number of unnecessary cystoscopies.","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"423-430"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10452061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Evaluation of the First Bahname Written in Turkish in the Ottoman Era Concerning Current Urology. 对奥斯曼帝国时期第一本用土耳其语撰写的有关当前泌尿外科的书名的评价。
IF 1 Q4 UROLOGY & NEPHROLOGY Pub Date : 2022-11-01 DOI: 10.5152/tud.2022.22104
Muhammet Ihsan Karaman, Adem Az

Objective: Our study investigated the oldest known Turkish bahname, translated by Musa b. Mes'ud, in comparison with the current literature.

Material and methods: First, the original manuscript of the translation was transcribed in Latin. The final version of the text was analyzed in the results. In discussion, findings were examined and interpreted within the framework of current knowledge of sexology, urology, and andrology.

Results: Although the work mostly mentions supportive and therapeutic practices in sexual health, it also provides advice on sexuality and sexual life, discussing several topics regarding sexual intercourse types, explaining which ones are good or harmful, and their timing or frequency. The author recommends many foods and compounds or specific drugs and ointments to enhance sexual stamina and avoid erectile dysfunc tion. In addition, he also tries to find solutions to some other sexual health problems related to men and women. These issues are generally evaluated in the context of health; a religious perspective is also provided when needed.

Conclusion: Interestingly, the author's recommendations on sexual health and herbal or animal drugs are consistent with the current literature. Nevertheless, some information and suggestions in works are entirely irrational and unscientific. Consequently, this study is an original investigation of the first translated bahname into Turkish. There is no other study examining the bahnames with this method. Thus, we believe that our work will be a significant contribution to the research literature.

目的:我们的研究调查了穆萨-本-梅苏德翻译的已知最古老的土耳其语巴哈名,并与现有文献进行了比较:我们的研究调查了由穆萨-贝-梅苏德(Musa b. Mes'ud)翻译的已知最古老的土耳其语梵名,并与现有文献进行了比较:首先,用拉丁文抄录了译文的原稿。结果分析了文本的最终版本。在讨论中,在当前性学、泌尿学和泌尿学知识的框架内研究和解释了研究结果:结果:虽然该著作主要提到了性健康方面的支持性和治疗性做法,但也提供了有关性生活和性生活的建议,讨论了有关性交类型的几个话题,解释了哪些是好的,哪些是有害的,以及性交的时间或频率。作者推荐了许多食物和化合物或特定药物和药膏,以增强性耐力,避免勃起障碍。此外,他还试图找到其他一些与男性和女性有关的性健康问题的解决方案。这些问题一般从健康的角度进行评价,必要时也会从宗教的角度进行分析:有趣的是,作者关于性健康和草药或动物药物的建议与现有文献一致。然而,著作中的一些信息和建议完全不合理、不科学。因此,本研究是对第一部翻译成土耳其语的《巴赫名》的原创性研究。目前还没有其他研究采用这种方法对咅名进行研究。因此,我们相信我们的工作将对研究文献做出重大贡献。
{"title":"The Evaluation of the First Bahname Written in Turkish in the Ottoman Era Concerning Current Urology.","authors":"Muhammet Ihsan Karaman, Adem Az","doi":"10.5152/tud.2022.22104","DOIUrl":"10.5152/tud.2022.22104","url":null,"abstract":"<p><strong>Objective: </strong>Our study investigated the oldest known Turkish bahname, translated by Musa b. Mes'ud, in comparison with the current literature.</p><p><strong>Material and methods: </strong>First, the original manuscript of the translation was transcribed in Latin. The final version of the text was analyzed in the results. In discussion, findings were examined and interpreted within the framework of current knowledge of sexology, urology, and andrology.</p><p><strong>Results: </strong>Although the work mostly mentions supportive and therapeutic practices in sexual health, it also provides advice on sexuality and sexual life, discussing several topics regarding sexual intercourse types, explaining which ones are good or harmful, and their timing or frequency. The author recommends many foods and compounds or specific drugs and ointments to enhance sexual stamina and avoid erectile dysfunc tion. In addition, he also tries to find solutions to some other sexual health problems related to men and women. These issues are generally evaluated in the context of health; a religious perspective is also provided when needed.</p><p><strong>Conclusion: </strong>Interestingly, the author's recommendations on sexual health and herbal or animal drugs are consistent with the current literature. Nevertheless, some information and suggestions in works are entirely irrational and unscientific. Consequently, this study is an original investigation of the first translated bahname into Turkish. There is no other study examining the bahnames with this method. Thus, we believe that our work will be a significant contribution to the research literature.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"446-454"},"PeriodicalIF":1.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10452060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revision Labiaplasty After Penile Inversion Vaginoplasty Using Costal Cartilage Allograft. 异体肋软骨移植阴茎内翻阴道成形术后阴唇矫正成形术。
IF 1.3 Q4 UROLOGY & NEPHROLOGY Pub Date : 2022-11-01 DOI: 10.5152/tud.2022.22079
Nicholas Sellke, Michael Callegari, Kirtishri Mishra, Tobias Long, Shubham Gupta

Background: Gender-affirming surgery leads to high satisfaction for patients; however, patients often require revision surgery. Revision labiaplasty is one of the most common surgeries following vaginoplasty. The labia minora commonly become incorporated into the labia majora and lose definition even after revision leading to patient dissatisfaction.

Description of technique: We propose a technique of incorporating cadaveric costal cartilage allograft into the revised labia minora to increase the definition.

Patient and methods: The procedure was demonstrated in a 38-year-old MTF patient who had previously undergone inversion vaginoplasty. The cartilage allograft was incorporated within the labia minora flaps dur ing labiaplasty.

Results: The patient had lasting definition of her labia minora post-operatively at 6 weeks without adverse effects.

Conclusion: We believe that this technique may be effective and safe in patients requesting more defined labia minora after vaginoplasty.

背景:性别确认手术患者满意度高;然而,患者通常需要翻修手术。阴唇矫正成形术是阴道成形术后最常见的手术之一。小阴唇通常并入大阴唇,甚至在翻修后失去清晰度,导致患者不满意。技术描述:我们提出一种将尸体肋软骨同种异体移植入改良小阴唇的技术,以增加小阴唇的清晰度。患者和方法:该手术是在一位38岁的MTF患者中进行的,他之前曾接受过阴道内翻成形术。在阴唇成形术中,将同种异体软骨植入小阴唇瓣内。结果:术后6周小阴唇轮廓持久,无不良反应。结论:我们相信该技术对阴道成形术后需要更明确的小阴唇的患者是有效和安全的。
{"title":"Revision Labiaplasty After Penile Inversion Vaginoplasty Using Costal Cartilage Allograft.","authors":"Nicholas Sellke,&nbsp;Michael Callegari,&nbsp;Kirtishri Mishra,&nbsp;Tobias Long,&nbsp;Shubham Gupta","doi":"10.5152/tud.2022.22079","DOIUrl":"https://doi.org/10.5152/tud.2022.22079","url":null,"abstract":"<p><strong>Background: </strong>Gender-affirming surgery leads to high satisfaction for patients; however, patients often require revision surgery. Revision labiaplasty is one of the most common surgeries following vaginoplasty. The labia minora commonly become incorporated into the labia majora and lose definition even after revision leading to patient dissatisfaction.</p><p><strong>Description of technique: </strong>We propose a technique of incorporating cadaveric costal cartilage allograft into the revised labia minora to increase the definition.</p><p><strong>Patient and methods: </strong>The procedure was demonstrated in a 38-year-old MTF patient who had previously undergone inversion vaginoplasty. The cartilage allograft was incorporated within the labia minora flaps dur ing labiaplasty.</p><p><strong>Results: </strong>The patient had lasting definition of her labia minora post-operatively at 6 weeks without adverse effects.</p><p><strong>Conclusion: </strong>We believe that this technique may be effective and safe in patients requesting more defined labia minora after vaginoplasty.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"455-459"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797741/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10818560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intestinal Microbiota Correction in the Treatment and Prevention of Urinary Tract Infection. 纠正肠道菌群在治疗和预防尿路感染中的作用。
IF 1.3 Q4 UROLOGY & NEPHROLOGY Pub Date : 2022-11-01 DOI: 10.5152/tud.2022.22119
Nikolay V Sturov, Sergey V Popov, Vladimir A Zhukov, Tatiana V Lyapunova, Ekaterina I Rusanova, Georgy N Kobylyanu

Intestinal microbiota is a topical subject of modern research. The maintenance of a healthy intestinal micro biota is an important component of homeostasis, and violations of its composition and functions, called dysbiosis, are associated with a number of diseases, including urinary tract infections. Antimicrobial therapy leads to significant changes in the intestinal microbiota and causes the possibility of urinary tract infection recurrence. In this regard, it is important to study methods of microbiota correction in order to restore its structural and functional integrity.

肠道菌群是现代研究的热门课题。维持健康的肠道微生物群是体内平衡的重要组成部分,违反其组成和功能,称为生态失调,与许多疾病有关,包括尿路感染。抗菌药物治疗导致肠道菌群发生显著变化,引起尿路感染复发的可能性。在这方面,研究微生物群校正方法以恢复其结构和功能的完整性是很重要的。
{"title":"Intestinal Microbiota Correction in the Treatment and Prevention of Urinary Tract Infection.","authors":"Nikolay V Sturov,&nbsp;Sergey V Popov,&nbsp;Vladimir A Zhukov,&nbsp;Tatiana V Lyapunova,&nbsp;Ekaterina I Rusanova,&nbsp;Georgy N Kobylyanu","doi":"10.5152/tud.2022.22119","DOIUrl":"https://doi.org/10.5152/tud.2022.22119","url":null,"abstract":"<p><p>Intestinal microbiota is a topical subject of modern research. The maintenance of a healthy intestinal micro biota is an important component of homeostasis, and violations of its composition and functions, called dysbiosis, are associated with a number of diseases, including urinary tract infections. Antimicrobial therapy leads to significant changes in the intestinal microbiota and causes the possibility of urinary tract infection recurrence. In this regard, it is important to study methods of microbiota correction in order to restore its structural and functional integrity.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"406-414"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10818554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Initial Experience of Hybrid Technique in Robot-Assisted Intracorporeal Ileal Conduit. 混合技术在机器人辅助体内回肠导管中的初步应用。
IF 1.3 Q4 UROLOGY & NEPHROLOGY Pub Date : 2022-11-01 DOI: 10.5152/tud.2022.22125
Shugo Yajima, Yasukazu Nakanishi, Yousuke Umino, Naoya Ookubo, Kenji Tanabe, Madoka Kataoka, Hitoshi Masuda

Objective: This study was designed to describe our hybrid approach to intracorporeal urinary diversion and evaluate surgical experience during initial induction.

Material and methods: Clinical data from 38 patients with bladder cancer undergoing robot-assisted radical cystectomy with ileal conduit hybrid approach to intracorporeal urinary diversion at our institution between May 2020 and January 2022 were reviewed. The hybrid approach to intracorporeal urinary diversion pro cedure involved the following: radical cystectomy, removing a specimen through a 4- to 6-cm skin incision, harvesting an ileal conduit, redocking the robot, and uretero-uretero anastomosis. The relationship between surgical experience and operative time and a Clavien-Dindo classification of grade >3 was evaluated.

Results: Of the 38 patients, 30 (79%) were male, and the median age was 75 years (interquartile range, 71-80 years). The total operative time was 384 minutes (interquartile range, 348-409 minutes). The estimated blood loss was 244 mL (interquartile range, 124-445 mL). No bowel injuries or conversions to laparoscopy or laparotomy were encountered. High-grade postoperative complications (Clavien-Dindo classification grade > 3) occurred in 7 cases (19%). The overall 90-day readmission rate following discharge after surgery was 5%. The relationship between surgical experience and operative time was nonlinear. A plateau was not reached in all 38 patients.

Conclusion: Our hybrid approach to intracorporeal urinary diversion technique can be accomplished safely with acceptable operative times, even with little surgical experience. This procedure might be a safe treat ment option that is relatively easy to perform, particularly in an institution that has not yet introduced intra corporeal urinary diversion. Future randomized trials with larger samples and longer follow-up periods are required to confirm our findings.

目的:本研究旨在描述我们的混合入路体外导尿术,并评估初始导尿术的手术经验。材料和方法:回顾我院2020年5月至2022年1月间行机器人辅助根治性膀胱切除术回肠导管混合入路体外导尿术的38例膀胱癌患者的临床资料。混合入路体内尿转移手术包括以下步骤:根治性膀胱切除术,通过4- 6厘米的皮肤切口切除标本,切除回肠导管,重新对接机器人,输尿管-输尿管吻合。评估手术经验、手术时间与Clavien-Dindo分级>3级的关系。结果:38例患者中,男性30例(79%),中位年龄75岁(四分位数范围71 ~ 80岁)。总手术时间384分钟(四分位数范围348 ~ 409分钟)。估计失血量为244毫升(四分位数范围为124-445毫升)。没有肠损伤或转到腹腔镜或开腹手术。术后发生高度并发症(Clavien-Dindo分级> 3)7例(19%)。术后出院后90天的再入院率为5%。手术经验与手术时间呈非线性关系。38例患者均未达到平台期。结论:我们所提出的混合入路体外导尿技术,即使缺乏手术经验,也能安全、可靠地完成手术时间。这种方法可能是一种相对容易实施的安全治疗选择,特别是在尚未引入体内尿转移的机构中。未来需要更大样本和更长随访期的随机试验来证实我们的发现。
{"title":"Initial Experience of Hybrid Technique in Robot-Assisted Intracorporeal Ileal Conduit.","authors":"Shugo Yajima,&nbsp;Yasukazu Nakanishi,&nbsp;Yousuke Umino,&nbsp;Naoya Ookubo,&nbsp;Kenji Tanabe,&nbsp;Madoka Kataoka,&nbsp;Hitoshi Masuda","doi":"10.5152/tud.2022.22125","DOIUrl":"https://doi.org/10.5152/tud.2022.22125","url":null,"abstract":"<p><strong>Objective: </strong>This study was designed to describe our hybrid approach to intracorporeal urinary diversion and evaluate surgical experience during initial induction.</p><p><strong>Material and methods: </strong>Clinical data from 38 patients with bladder cancer undergoing robot-assisted radical cystectomy with ileal conduit hybrid approach to intracorporeal urinary diversion at our institution between May 2020 and January 2022 were reviewed. The hybrid approach to intracorporeal urinary diversion pro cedure involved the following: radical cystectomy, removing a specimen through a 4- to 6-cm skin incision, harvesting an ileal conduit, redocking the robot, and uretero-uretero anastomosis. The relationship between surgical experience and operative time and a Clavien-Dindo classification of grade >3 was evaluated.</p><p><strong>Results: </strong>Of the 38 patients, 30 (79%) were male, and the median age was 75 years (interquartile range, 71-80 years). The total operative time was 384 minutes (interquartile range, 348-409 minutes). The estimated blood loss was 244 mL (interquartile range, 124-445 mL). No bowel injuries or conversions to laparoscopy or laparotomy were encountered. High-grade postoperative complications (Clavien-Dindo classification grade > 3) occurred in 7 cases (19%). The overall 90-day readmission rate following discharge after surgery was 5%. The relationship between surgical experience and operative time was nonlinear. A plateau was not reached in all 38 patients.</p><p><strong>Conclusion: </strong>Our hybrid approach to intracorporeal urinary diversion technique can be accomplished safely with acceptable operative times, even with little surgical experience. This procedure might be a safe treat ment option that is relatively easy to perform, particularly in an institution that has not yet introduced intra corporeal urinary diversion. Future randomized trials with larger samples and longer follow-up periods are required to confirm our findings.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"415-422"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10452057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biopsy with Ureterorenoscopy Before Radical Nephroureterectomy is Associated with Increased Intravesical Recurrence in Urothelial Cancer Located in the Kidney. 根治性肾输尿管切除术前输尿管镜活检与位于肾脏的尿路上皮癌膀胱内复发增加相关。
IF 1.3 Q4 UROLOGY & NEPHROLOGY Pub Date : 2022-11-01 DOI: 10.5152/tud.2022.22143
Meftun Culpan, Mehmet Caglar Cakici, Ferhat Keser, Mehmet Yigit Yalcin, Taner Kargi, Rıdvan Kayar, Erdal Abay, Gorkem Ozenc, Ali Kumcu, Mehmet Pehlivanoglu, Semih Turk, Erdem Kisa, Selcuk Sahin, Metin Ishak Ozturk, Alper Otunctemur, Resul Sobay, Huseyin Cihan Demirel, Omer Yilmaz, Gokhan Atis, Muhammet Abdurrahim Imamoglu, Asif Yildirim

Objective: Diagnostic ureterorenoscopy is used to identify upper tract urothelial cancer before radical nephro ureterectomy, especially for uncertain lesions in imaging modalities or urine cytology. However, diagnostic ureterorenoscopy can potentially cause intravesical tumor spillage and can increase intravesical recurrence rates. We aimed to investigate the impact of diagnostic ureterorenoscopy before radical nephroureterectomy, with and without biopsy, on intravesical recurrence rates of patients with upper tract urothelial cancer.

Material and methods: Patients with localized upper tract urothelial cancer from 8 different tertiary referral centers, who underwent radical nephroureterectomy between 2001 and 2020, were included. Three groups were made: no URS (group 1); diagnostic ureterorenoscopy without biopsy (group 2); and diagnostic ure terorenoscopy with biopsy (group 3). Intravesical recurrence rates and survival outcomes were compared. Univariate and multivariate Cox regression analyses were performed to determine the factors that were asso ciated with intravesical recurrence-free survival.

Results: Twenty-two (20.8%), 10 (24.4%), and 23 (39%) patients experienced intravesical recurrence in groups 1, 2, and 3, respectively (P=.037) among 206 patients. The 2-year intravesical recurrence-free sur vival rate was 83.1%, 82.4%, and 69.2%, for groups 1, 2, and 3, respectively (P=.004). Cancer-specific survival and overall survival were comparable (P=.560 and P=.803, respectively). Diagnostic ureterore noscopy+biopsy (hazard ratio: 6.88, 95% CI: 2.41-19.65, P < .001) was the only independent predictor of intravesical recurrence in patients with upper tract urothelial cancer located in the kidney, according to tumor location.

Conclusion: Diagnostic ureterorenoscopy+biopsy before radical nephroureterectomy significantly increased the rates of intravesical recurrence in tumors located in kidney. This result suggests tumor spillage with this type of biopsy, so further studies with different biopsy options or without biopsy can be designed.

目的:诊断性输尿管镜检查用于根治性肾输尿管切除术前鉴别上尿路尿路上皮癌,特别是对于影像学或尿细胞学上不确定的病变。然而,诊断性输尿管镜检查可能导致膀胱内肿瘤溢出,并增加膀胱内复发率。我们的目的是探讨根治性肾输尿管切除术前诊断性输尿管镜检查对上尿路上皮癌患者膀胱内复发率的影响,包括活检和不活检。材料和方法:纳入来自8个不同三级转诊中心的2001 - 2020年间行根治性肾输尿管切除术的局限性上尿路上皮癌患者。分为三组:无URS(第一组);诊断性输尿管镜检查无活检(2组);诊断性输尿管镜活检(组3)。比较膀胱内复发率和生存结果。进行单因素和多因素Cox回归分析,以确定与膀胱内无复发生存相关的因素。结果:206例患者中,1、2、3组分别有22例(20.8%)、10例(24.4%)、23例(39%)出现膀胱内复发(P= 0.037)。1、2、3组2年无膀胱内复发生存率分别为83.1%、82.4%、69.2% (P= 0.004)。癌症特异性生存期和总生存期比较(P=。560, P=。803年,分别)。诊断性输尿管镜检查+活检(危险比:6.88,95% CI: 2.41-19.65, P < 0.001)是肾上路尿路癌患者膀胱内复发的唯一独立预测因子。结论:肾输尿管根治术前诊断性输尿管镜检查+活检可显著增加肾脏肿瘤膀胱内复发率。该结果提示该类型活检存在肿瘤溢漏,因此可以设计不同活检选择或不活检的进一步研究。
{"title":"Biopsy with Ureterorenoscopy Before Radical Nephroureterectomy is Associated with Increased Intravesical Recurrence in Urothelial Cancer Located in the Kidney.","authors":"Meftun Culpan,&nbsp;Mehmet Caglar Cakici,&nbsp;Ferhat Keser,&nbsp;Mehmet Yigit Yalcin,&nbsp;Taner Kargi,&nbsp;Rıdvan Kayar,&nbsp;Erdal Abay,&nbsp;Gorkem Ozenc,&nbsp;Ali Kumcu,&nbsp;Mehmet Pehlivanoglu,&nbsp;Semih Turk,&nbsp;Erdem Kisa,&nbsp;Selcuk Sahin,&nbsp;Metin Ishak Ozturk,&nbsp;Alper Otunctemur,&nbsp;Resul Sobay,&nbsp;Huseyin Cihan Demirel,&nbsp;Omer Yilmaz,&nbsp;Gokhan Atis,&nbsp;Muhammet Abdurrahim Imamoglu,&nbsp;Asif Yildirim","doi":"10.5152/tud.2022.22143","DOIUrl":"https://doi.org/10.5152/tud.2022.22143","url":null,"abstract":"<p><strong>Objective: </strong>Diagnostic ureterorenoscopy is used to identify upper tract urothelial cancer before radical nephro ureterectomy, especially for uncertain lesions in imaging modalities or urine cytology. However, diagnostic ureterorenoscopy can potentially cause intravesical tumor spillage and can increase intravesical recurrence rates. We aimed to investigate the impact of diagnostic ureterorenoscopy before radical nephroureterectomy, with and without biopsy, on intravesical recurrence rates of patients with upper tract urothelial cancer.</p><p><strong>Material and methods: </strong>Patients with localized upper tract urothelial cancer from 8 different tertiary referral centers, who underwent radical nephroureterectomy between 2001 and 2020, were included. Three groups were made: no URS (group 1); diagnostic ureterorenoscopy without biopsy (group 2); and diagnostic ure terorenoscopy with biopsy (group 3). Intravesical recurrence rates and survival outcomes were compared. Univariate and multivariate Cox regression analyses were performed to determine the factors that were asso ciated with intravesical recurrence-free survival.</p><p><strong>Results: </strong>Twenty-two (20.8%), 10 (24.4%), and 23 (39%) patients experienced intravesical recurrence in groups 1, 2, and 3, respectively (P=.037) among 206 patients. The 2-year intravesical recurrence-free sur vival rate was 83.1%, 82.4%, and 69.2%, for groups 1, 2, and 3, respectively (P=.004). Cancer-specific survival and overall survival were comparable (P=.560 and P=.803, respectively). Diagnostic ureterore noscopy+biopsy (hazard ratio: 6.88, 95% CI: 2.41-19.65, P < .001) was the only independent predictor of intravesical recurrence in patients with upper tract urothelial cancer located in the kidney, according to tumor location.</p><p><strong>Conclusion: </strong>Diagnostic ureterorenoscopy+biopsy before radical nephroureterectomy significantly increased the rates of intravesical recurrence in tumors located in kidney. This result suggests tumor spillage with this type of biopsy, so further studies with different biopsy options or without biopsy can be designed.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"431-439"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797743/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10818556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of 175 Cases of Tuberculosis Infections Affecting the Urogenital System. 泌尿生殖系统结核感染175例分析。
IF 1.3 Q4 UROLOGY & NEPHROLOGY Pub Date : 2022-11-01 DOI: 10.5152/tud.2022.22148
Nuno Dias, Teresa Pina-Vaz, Pedro Abreu-Mendes, Tiago Azeredo-Costa, Pedro Rodrigues-Pereira, Carlos Silva, Francisco Botelho

Objective: Urogenital tuberculosis and disseminated tuberculosis affecting urogenital system are more fre quent in developing countries but are often overlooked in developed ones. We aimed to compare clinical characteristics and outcomes of urogenital tuberculosis and disseminated tuberculosis affecting the urogeni tal system.

Material and methods: We retrospectively reviewed data from patients with tuberculosis in the urogenital system, diagnosed in a tertiary center in a European country, from 2008 to 2018. Cases were divided into urogenital tuberculosis and disseminated tuberculosis affecting the urogenital system and compared.

Results: We included 172 patients, 31 with urogenital tuberculosis and 141 with disseminated tuberculosis affecting urogenital system. Patients with disseminated tuberculosis affecting the urogenital system were younger (median 45 vs. 64 years, P=.001), more likely to be male (80 vs. 55%, P=.005), or having risk fac tors for the disease (84 vs. 23%, P=.005) than patients with urogenital tuberculosis. Patients with urogenital tuberculosis presented most commonly with symptoms related to the urinary tract, with 52% complaining of lower urinary tract symptoms attributed to urinary tract infections and 48% of dysuria, while patients with disseminated tuberculosis affecting the urogenital system presented mainly with systemic symptoms, with 89% complaining of malaise, 62% of fever, and 57% of anorexia. Patients with urogenital tuberculosis were more likely to need urological surgery as part of their treatment (71 vs. 5%, P < .001) and patients with dis seminated tuberculosis affecting the urogenital system were more likely to die due to tuberculosis (10 vs. 21%, P < .001).

Conclusion: Tuberculosis of the urogenital system can have multiple clinical presentations, and a simple diagnostic algorithm does not exist. In the presence of urogenital tuberculosis in injected drug users, immu nosuppressed individuals, or patients with systemic symptoms, we should think of disseminated tuberculosis affecting the urogenital system and remember these patients less frequently need surgery but entail a worst outcome.

目的:泌尿生殖系统结核和影响泌尿生殖系统的播散性结核在发展中国家较为常见,但在发达国家却经常被忽视。我们的目的是比较泌尿生殖系统结核和影响泌尿生殖系统的播散性结核的临床特征和结果。材料和方法:我们回顾性回顾了2008年至2018年在欧洲国家三级医疗中心诊断的泌尿生殖系统结核病患者的数据。将病例分为泌尿生殖系统结核和影响泌尿生殖系统的播散性结核,并进行比较。结果:纳入172例患者,其中31例为泌尿生殖系统结核,141例为泌尿生殖系统弥散性结核。与泌尿生殖系统结核患者相比,播散性结核影响泌尿生殖系统的患者更年轻(中位年龄为45岁vs. 64岁,P= 0.001),更可能是男性(80比55%,P= 0.005),或具有该疾病的危险因素(84比23%,P= 0.005)。泌尿生殖系统结核患者最常见的症状是与尿路相关的症状,52%的患者主诉尿路感染引起的下尿路症状,48%的患者主诉排尿困难,而影响泌尿生殖系统的弥散性结核患者主要表现为全身性症状,89%的患者主诉不适,62%的患者主诉发热,57%的患者主诉厌食。泌尿生殖系统结核患者更有可能需要泌尿外科手术作为其治疗的一部分(71比5%,P < .001),而影响泌尿生殖系统的弥散性结核患者更有可能死于结核病(10比21%,P < .001)。结论:泌尿生殖系统结核具有多种临床表现,不存在简单的诊断算法。在注射吸毒者、免疫功能不受抑制的个体或有全身性症状的患者中出现泌尿生殖系统结核时,我们应该考虑影响泌尿生殖系统的播散性结核,并记住这些患者很少需要手术,但结果最差。
{"title":"Review of 175 Cases of Tuberculosis Infections Affecting the Urogenital System.","authors":"Nuno Dias,&nbsp;Teresa Pina-Vaz,&nbsp;Pedro Abreu-Mendes,&nbsp;Tiago Azeredo-Costa,&nbsp;Pedro Rodrigues-Pereira,&nbsp;Carlos Silva,&nbsp;Francisco Botelho","doi":"10.5152/tud.2022.22148","DOIUrl":"https://doi.org/10.5152/tud.2022.22148","url":null,"abstract":"<p><strong>Objective: </strong>Urogenital tuberculosis and disseminated tuberculosis affecting urogenital system are more fre quent in developing countries but are often overlooked in developed ones. We aimed to compare clinical characteristics and outcomes of urogenital tuberculosis and disseminated tuberculosis affecting the urogeni tal system.</p><p><strong>Material and methods: </strong>We retrospectively reviewed data from patients with tuberculosis in the urogenital system, diagnosed in a tertiary center in a European country, from 2008 to 2018. Cases were divided into urogenital tuberculosis and disseminated tuberculosis affecting the urogenital system and compared.</p><p><strong>Results: </strong>We included 172 patients, 31 with urogenital tuberculosis and 141 with disseminated tuberculosis affecting urogenital system. Patients with disseminated tuberculosis affecting the urogenital system were younger (median 45 vs. 64 years, P=.001), more likely to be male (80 vs. 55%, P=.005), or having risk fac tors for the disease (84 vs. 23%, P=.005) than patients with urogenital tuberculosis. Patients with urogenital tuberculosis presented most commonly with symptoms related to the urinary tract, with 52% complaining of lower urinary tract symptoms attributed to urinary tract infections and 48% of dysuria, while patients with disseminated tuberculosis affecting the urogenital system presented mainly with systemic symptoms, with 89% complaining of malaise, 62% of fever, and 57% of anorexia. Patients with urogenital tuberculosis were more likely to need urological surgery as part of their treatment (71 vs. 5%, P < .001) and patients with dis seminated tuberculosis affecting the urogenital system were more likely to die due to tuberculosis (10 vs. 21%, P < .001).</p><p><strong>Conclusion: </strong>Tuberculosis of the urogenital system can have multiple clinical presentations, and a simple diagnostic algorithm does not exist. In the presence of urogenital tuberculosis in injected drug users, immu nosuppressed individuals, or patients with systemic symptoms, we should think of disseminated tuberculosis affecting the urogenital system and remember these patients less frequently need surgery but entail a worst outcome.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"440-445"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10818558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Molecular Mechanism of Action of Low-Intensity Extracorporeal Shockwave Therapy for Regenerating Penile and Peripheral Nerves. 低强度体外冲击波治疗阴茎和周围神经再生的分子机制。
IF 1.3 Q4 UROLOGY & NEPHROLOGY Pub Date : 2022-09-01 DOI: 10.5152/tud.2022.20419
Dongyi Peng, Yan Tan, Amanda B Reed-Maldonado, Guiting Lin, Tom F Lue

Sufficient functional repair of damaged peripheral nerves is a big clinical challenge in terms of long-lasting morbidity, disability, and economic costs. Nerve damage after radical prostatectomy is the most common cause of erectile dysfunction. In recent years, low-intensity extracorporeal shockwave therapy has been explored to improve the outcomes of peripheral nerve repair and regeneration. Research indicated that application of low-intensity extracorporeal shockwave therapy after nerve surgery promoted nerve regeneration and improved the functional outcomes, underlined the mechanisms related to increase of neurotrophic factors, Schwann cells activation, and cellular signaling activation for cell activation and mitosis induced by low-intensity extracorporeal shockwave therapy. We searched PubMed for articles related to research on these topics in both in vitro and in vivo animal models and found numerous studies suggesting that the application low-intensity extracorporeal shockwave therapy could be a novel treatment for erectile dysfunction induced by nerve injury and other disease related to nerve injury.

从长期发病、致残和经济成本的角度来看,对受损周围神经进行充分的功能修复是一个巨大的临床挑战。根治性前列腺切除术后的神经损伤是勃起功能障碍最常见的原因。近年来,低强度体外冲击波治疗被用于改善周围神经修复和再生的效果。研究表明,神经手术后应用低强度体外冲击波治疗可促进神经再生,改善功能预后,强调了低强度体外冲击波治疗诱导细胞活化和有丝分裂与神经营养因子增加、雪旺细胞活化和细胞信号活化有关的机制。我们在PubMed检索了与这些主题相关的体外和体内动物模型研究的文章,发现大量研究表明,应用低强度体外冲击波治疗可能是一种治疗神经损伤和其他与神经损伤相关疾病引起的勃起功能障碍的新方法。
{"title":"Molecular Mechanism of Action of Low-Intensity Extracorporeal Shockwave Therapy for Regenerating Penile and Peripheral Nerves.","authors":"Dongyi Peng,&nbsp;Yan Tan,&nbsp;Amanda B Reed-Maldonado,&nbsp;Guiting Lin,&nbsp;Tom F Lue","doi":"10.5152/tud.2022.20419","DOIUrl":"https://doi.org/10.5152/tud.2022.20419","url":null,"abstract":"<p><p>Sufficient functional repair of damaged peripheral nerves is a big clinical challenge in terms of long-lasting morbidity, disability, and economic costs. Nerve damage after radical prostatectomy is the most common cause of erectile dysfunction. In recent years, low-intensity extracorporeal shockwave therapy has been explored to improve the outcomes of peripheral nerve repair and regeneration. Research indicated that application of low-intensity extracorporeal shockwave therapy after nerve surgery promoted nerve regeneration and improved the functional outcomes, underlined the mechanisms related to increase of neurotrophic factors, Schwann cells activation, and cellular signaling activation for cell activation and mitosis induced by low-intensity extracorporeal shockwave therapy. We searched PubMed for articles related to research on these topics in both in vitro and in vivo animal models and found numerous studies suggesting that the application low-intensity extracorporeal shockwave therapy could be a novel treatment for erectile dysfunction induced by nerve injury and other disease related to nerve injury.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 5","pages":"354-362"},"PeriodicalIF":1.3,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9984141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Applications of Artificial Intelligence in Benign Prostatic Hyperplasia. 人工智能在良性前列腺增生中的应用现状。
IF 1.3 Q4 UROLOGY & NEPHROLOGY Pub Date : 2022-07-01 DOI: 10.5152/tud.2022.22028
Milap Shah, Nithesh Naik, Bm Zeeshan Hameed, Rahul Paul, Dasharathraj K Shetty, Sufyan Ibrahim, Bhavan Prasad Rai, Piotr Chlosta, Patrick Rice, Bhaskar K Somani

Artificial intelligence is used in predicting the clinical outcomes before minimally invasive treatments for benign prostatic hyperplasia, to address the insufficient reliability despite multiple assessment parameters, such as flow rates and symptom scores. Various models of artificial intelligence and its contemporary applications in benign prostatic hyperplasia are reviewed and discussed. A search strategy adapted to identify and review the literature on the application of artificial intelligence with a dedicated search string with the following keywords: "Machine Learning," "Artificial Intelligence," AND "Benign Prostate Enlargement" OR "BPH" OR "Benign Prostatic Hyperplasia" was included and categorized. Review articles, editorial comments, and non-urologic studies were excluded. In the present review, 1600 patients were included from 4 studies that used different classifiers such as fuzzy systems, computer-based vision systems, and clinical data mining to study the applications of artificial intelligence in diagnoses and severity prediction and determine clinical factors responsible for treatment response in benign prostatic hyperplasia. The accuracy to correctly diagnose benign prostatic hyperplasia by Fuzzy systems was 90%, while that of computer-based vision system was 96.3%. Data mining achieved sensitivity and specificity of 70% and 50%, respectively, in correctly predicting the clinical response to medical treatment in benign prostatic hyperplasia. Artificial intelligence is gaining attraction in urology, with the potential to improve diagnostics and patient care. The results of artificial intelligence-based applications in benign prostatic hyperplasia are promising but lack generalizability of results. However, in the future, we will see a shift in the clinical paradigm as artificial intelligence applications will find their place in the guidelines and revolutionize the decision-making process.

应用人工智能预测良性前列腺增生微创治疗前的临床结果,解决了在流速、症状评分等多个评估参数下可靠性不足的问题。综述了各种人工智能模型及其在良性前列腺增生中的应用。检索策略适用于识别和审查人工智能应用方面的文献,包含以下关键词的专用搜索字符串:“机器学习”,“人工智能”和“良性前列腺增大”或“BPH”或“良性前列腺增生”。综述文章、编辑评论和非泌尿学研究被排除在外。在本综述中,来自4项研究的1600例患者,使用模糊系统、计算机视觉系统和临床数据挖掘等不同分类器,研究人工智能在良性前列腺增生诊断和严重程度预测中的应用,并确定导致治疗反应的临床因素。模糊系统诊断前列腺增生的正确率为90%,计算机视觉系统诊断前列腺增生的正确率为96.3%。数据挖掘在正确预测良性前列腺增生患者对药物治疗的临床反应方面的敏感性和特异性分别达到70%和50%。人工智能在泌尿外科领域越来越有吸引力,有可能改善诊断和病人护理。人工智能在前列腺增生中的应用前景广阔,但结果缺乏普遍性。然而,在未来,我们将看到临床模式的转变,因为人工智能应用将在指南中找到自己的位置,并彻底改变决策过程。
{"title":"Current Applications of Artificial Intelligence in Benign Prostatic Hyperplasia.","authors":"Milap Shah,&nbsp;Nithesh Naik,&nbsp;Bm Zeeshan Hameed,&nbsp;Rahul Paul,&nbsp;Dasharathraj K Shetty,&nbsp;Sufyan Ibrahim,&nbsp;Bhavan Prasad Rai,&nbsp;Piotr Chlosta,&nbsp;Patrick Rice,&nbsp;Bhaskar K Somani","doi":"10.5152/tud.2022.22028","DOIUrl":"https://doi.org/10.5152/tud.2022.22028","url":null,"abstract":"<p><p>Artificial intelligence is used in predicting the clinical outcomes before minimally invasive treatments for benign prostatic hyperplasia, to address the insufficient reliability despite multiple assessment parameters, such as flow rates and symptom scores. Various models of artificial intelligence and its contemporary applications in benign prostatic hyperplasia are reviewed and discussed. A search strategy adapted to identify and review the literature on the application of artificial intelligence with a dedicated search string with the following keywords: \"Machine Learning,\" \"Artificial Intelligence,\" AND \"Benign Prostate Enlargement\" OR \"BPH\" OR \"Benign Prostatic Hyperplasia\" was included and categorized. Review articles, editorial comments, and non-urologic studies were excluded. In the present review, 1600 patients were included from 4 studies that used different classifiers such as fuzzy systems, computer-based vision systems, and clinical data mining to study the applications of artificial intelligence in diagnoses and severity prediction and determine clinical factors responsible for treatment response in benign prostatic hyperplasia. The accuracy to correctly diagnose benign prostatic hyperplasia by Fuzzy systems was 90%, while that of computer-based vision system was 96.3%. Data mining achieved sensitivity and specificity of 70% and 50%, respectively, in correctly predicting the clinical response to medical treatment in benign prostatic hyperplasia. Artificial intelligence is gaining attraction in urology, with the potential to improve diagnostics and patient care. The results of artificial intelligence-based applications in benign prostatic hyperplasia are promising but lack generalizability of results. However, in the future, we will see a shift in the clinical paradigm as artificial intelligence applications will find their place in the guidelines and revolutionize the decision-making process.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 4","pages":"262-267"},"PeriodicalIF":1.3,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612697/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40673387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turkish journal of urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1